Belgium· BE-AMP-SAM666452-00

Bimervax XFG.1.1

A covid-19, protein-untereinheit product containing sars-cov-2 virus, variant xfg.1.1, spike protein, receptor binding domain fusion homodimer, registered in Belgium by Hipra Human Health. The same ATC class is registered in 10 of our 19 countries.

ATC J07BN04

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about sars-cov-2 virus, variant xfg.1.1, spike protein, receptor binding domain fusion homodimerAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Covid-19, protein-untereinheit is registered in 10 of 19 countries.

Countries holding a registration under ATC J07BN04 (covid-19, protein-untereinheit), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
6 of them publish a price we can compare per daily dose

Search covid-19, protein-untereinheit products by name

Covid-19, protein-untereinheit · ATC J07BN04

10 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: SARS-CoV-2 Virus, Variant XFG.1.1, Spike Protein, Receptor Binding Domain Fusion Homodimer
Manufacturer: Hipra Human Health
Country: Belgium (BE)
ATC code: J07BN04
ATC class: Covid-19, Protein-Untereinheit
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 1

be_apb
5870688

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BN04

Covid-19, protein-untereinheit, as other registers publish it.

All covid-19, protein-untereinheit products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e1f29556-58e3-4202-9c92-bf6130bd4ceb
GET /v1/drugs/e1f29556-58e3-4202-9c92-bf6130bd4ceb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsion for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Bimervax XFG.1.1",
  "name_fr": "Bimervax XFG.1.1",
  "name_nl": "Bimervax XFG.1.1",
  "amp_code": "SAM666452-00",
  "strengths": [
    "40.0000",
    "1.1800"
  ],
  "pack_count": 3,
  "substances": [
    "SARS-CoV-2 Virus, Variant XFG.1.1, Spike Protein, Receptor Binding Domain Fusion Homodimer",
    "Sodium Chloride",
    "Disodium Hydrogen Phosphate Dodecahydrate",
    "Polysorbate 80",
    "Potassium Dihydrogen Phosphate",
    "Potassium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Covid-19, Protein Subunit",
  "authorisation_numbers": [
    "EU/1/22/1709/015",
    "EU/1/22/1709/013",
    "EU/1/22/1709/014"
  ]
}

API reference MCP server Plans

See everything about covid-19, protein-untereinheit.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console